Solid Biosciences Inc. SLDB Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s total operating expenses?
- Solid Biosciences Inc. (SLDB) reported total operating expenses of $57.31M in Q1 2026.
- How has Solid Biosciences Inc.'s total operating expenses changed year-over-year?
- Solid Biosciences Inc.'s total operating expenses increased by 43.1% year-over-year, from $40.05M to $57.31M.
- What is the long-term trend for Solid Biosciences Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s total operating expenses has grown at a 20.2% compound annual growth rate (CAGR), from $85.87M to $179.21M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.